Maxim Group Reaffirms Their Hold Rating on Aethlon Medical (AEMD)

Tip Ranks
2025.11.14 12:56
portai
I'm PortAI, I can summarize articles.

Maxim Group's Anthony Vendetti reaffirmed a Hold rating on Aethlon Medical (AEMD) in a report dated November 12. The stock closed at $4.20. Vendetti, with an average return of -23.2% and a 25.86% success rate, covers the Healthcare sector. The analyst consensus for Aethlon Medical remains a Hold rating.

In a report released on November 12, Anthony Vendetti from Maxim Group maintained a Hold rating on Aethlon Medical. The company’s shares closed yesterday at $4.20.

Meet Your ETF AI Analyst

  • Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
  • Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.

According to TipRanks, Vendetti is an analyst with an average return of -23.2% and a 25.86% success rate. Vendetti covers the Healthcare sector, focusing on stocks such as Lucid Diagnostics, Rockwell Med, and NeuroOne Medical Technologies.

The analyst consensus on Aethlon Medical is currently a Hold rating.

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer